Your Results: Displaying 26-50 of 227 from the Free Pamphlets collection.
Growth Failure In Children With Kidney Disease
Guidance : Expiration Dating Of Unit-Dose Repackaged Drugs, Compliance Policy Guide
Guidance : Open Public Meeting : FDA Advisory Committee Meetings
Guidance For Clinical Investigators, Institutional Review Boards, And Sponsors : Process For Handling Referrals To FDA Under 21 CFR 50.54 : Additional Safeguards For Children In Clinical Investigations
Guidance for FDA Advisory Committee Members and FDA Staff : Voting Procedures for Advisory Committee Meetings
Guidance For FDA Reviewers : Premarket Notification Submissions For Transfer Sets (Excluding Sterile Connecting Sets)
Guidance For FDA Staff And Industry : Marketed Unapproved Drugs, Compliance Policy Guide
Guidance For Hospitals, Nursing Homes And Other Health Care Facilities
Guidance For Industry : Postmarketing Studies And Clinical Trials, Implementation Of Section 505(O) Of The Federal Food, Drug, And Cosmetic Act.
Guidance For Industry : Prescription Drug Marketing Act (PDMA) Requirements, Questions And Answers
Guidance For Industry : Prescription Drug Marketing Act, Donation Of Prescription Drug Samples To Free Clinics
Guidance For Industry : SPL Standard For Content Of Labeling Technical Qs & As
Guidance For Industry : 180-Day Exclusivity When Multiple Andas Are Submitted On The Same Day.
Guidance For Industry : Court Decisions, ANDA Approvals, And 180-Day Exclusivity Under The Hatch-Waxman Amendments To The Federal Food, Drug, And Cosmetic Act
Guidance For Industry : Investigating Out-Of-Specification Test Results (OOS) For Pharmaceutical Production.
Guidance For Industry : Powder Blends And Finished Dosage Units : Stratified In-Process Dosage Unit Sampling And Assessment
Guidance for Industry : "Lookback" for Hepatitis C Virus (HCV): Product Quarantine, Consignee Notification, Further Testing, Product Disposition, and Notification of Transfusion Recipients Based on Donor Test Results Indicating Infection with HCV
Guidance for Industry : 21 CFR Part 11; Electronic Records; Electronic Signatures Validation
Guidance For Industry : Accelerated Approval Products, Submission Of Promotional Materials
Guidance For Industry : Acute Bacterial Exacerbations Of Chronic Bronchitis In Patients With Chronic Obstructive Pulmonary Disease : Developing Antimicrobial Drugs For Treatment
Guidance For Industry : Acute Bacterial Otitis Media, Developing Drugs For Treatment
Guidance For Industry : Acute Bacterial Sinusitis, Developing Drugs For Treatment
Guidance For Industry : Acute Or Chronic Bacterial Prostatitis, Developing Antimicrobial Drugs For Treatment
Guidance For Industry : Addendum To E2C Clinical Safety Data Management : Periodic Safety Update Reports For Marketed Drugs
Guidance For Industry : Adverse Reactions Section Of Labeling For Human Prescription Drug And Biological Products, Content And Format
Access Information Key